Rebecca Pifer

The flat-out denial comes after Cigna CEO David Cordani tried to throw cold water on persistent speculation of a Humana merger earlier this fall.

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s how some of the most influential industry groups responded to the Republican’s reelection.

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals after-the-fact rebates for two drugs in the 340B drug discount program, instead of offering upfront discounts.

Fasola is the second-highest paid executive at the insurer, trailing only CEO Sarah London.

Regulators’ assessment of customer support centers has spurred recent lawsuits from UnitedHealthcare, Centene and Humana. But the metric “is going to have a smaller weighting on star ratings moving forward,” the director of Medicare said.

Regulators' assessment of customer support centers has spurred recent lawsuits from UnitedHealthcare, Centene and Humana.

In the third quarter, the seven major publicly traded insurers’ medical loss ratios increased an average of 3.3 percentage points year over year — a major jump in medical costs.

Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead of giving them upfront discounts on 340B drugs.

Mike Pykosz is leaving 18 months after he joined CVS with its acquisition of the value-based medical chain. He’s departing amid a flurry of high-level ousters at the struggling company — but isn’t one himself, CVS said.

The three companies are claiming the FTC's suit is unconstitutional because it was lodged in the agency's administrative court, instead of a federal one.